82 F Clouds
Thursday, Nov 26 2020, 09:41 AM
Close Ad
Back To Listing

HSA alerts public of low-levels of contamination in ranitidine

Community Notices 27 Sep, 2019 Follow News

HSA alerts public of low-levels of contamination in ranitidine

The US Food and Drug Administration (FDA) has issued a statement regarding the safety of the drug ranitidine (Zantac®) after the detection of low-levels of contamination.

The FDA and several health regulatory bodies including the Health Canada and the European Medicines Agency are conducting an evaluation on this matter.

The Cayman Islands Health Services Authority (HSA) is aware of the issue and is closely monitoring the evaluation. Once the aforementioned agencies release more information, the HSA will provide an update. In the meantime, the organization is recommending that patients continue taking their ranitidine as prescribed.


Comments (0)

We appreciate your feedback. You can comment here with your pseudonym or real name. You can leave a comment with or without entering an email address. All comments will be reviewed before they are published.

* Denotes Required Inputs